In the Mix — Last 24 HoursMarch 15, 2026. 5 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25Budget Battle, Clyburn to Run Again,...
New Top Cannabis Regulator Sets Priorities In First Board Meeting
✦ New CED Clinical Relevance #96 Landmark Clinical Evidence Peer-reviewed human research with direct implications for cannabis medicine practice. PolicyIndustrySafety Why This Matters I don't see a summary provided in your message....
Quasi-randomization to Cannabinoid Condition in Studies of US Legal Market Cannabis
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchPolicySafety Why This Matters Clinicians need to understand that most cannabis efficacy data comes from...
This Week in Cannabis: March 13, 2026
Weekly RoundupThis week, cannabis coverage focused on federal reclassification impacts, clinical research into CBD and cannabinoids for health conditions, and regulatory policy updates.Friday, March 13, 2026 — top 5 across News, Studies,...
Marijuana Rescheduling Is A ‘Transitional’ Step That Must Be Followed By Banking …
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Clinical Summary Federal rescheduling of marijuana from Schedule I to Schedule III would represent...
In the Mix: 5 More Articles — March 13, 2026
In the Mix — Last 24 HoursMarch 13, 2026. 5 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25 Marijuana reclassification may impact drug...
IRS Files First Response to Common Industry 280E Arguments | Harris Beach Murtha – JDSupra
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearch Why This Matters The IRS’s response to Section 280E tax deduction arguments directly impacts...
In the Mix: 7 More Articles — March 12, 2026
In the Mix — Last 24 HoursMarch 12, 2026. 7 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25 IRS Files First Response to...
9th Circuit says Dormant Commerce Clause does not apply to cannabis, sparking circuit split
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Why This Matters This ruling creates legal uncertainty about interstate cannabis commerce, which could...
IRS disputes cannabis company’s tax argument (Newsletter: March 12, 2026)
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearch Why This Matters Cannabis companies’ ongoing tax disputes with the IRS create financial uncertainty...